Abstract
Melanomas are common cancers among people of European ancestry, and incidence has been rising in most populations where fair-skinned people predominate. The principal environmental risk factor for cutaneous melanoma is solar ultraviolet radiation, although the association is nonlinear and modified by host factors. While overall, fair-skinned populations residing in regions of high ambient insolation have higher rates of melanoma than those residing in regions receiving less sunlight, it is also generally observed that outdoor workers have lower risks of melanoma than indoor workers. A suite of host phenotypic characteristics confer increased relative risks of melanoma including fair complexion, skin that burns and does not tan, red hair, freckling, and blue eyes. Those with a propensity for developing large numbers of melanocytic nevi also have markedly increased risks of melanoma. Recently, algorithms have been developed that combine information about various phenotypic characteristics to derive an overall summary risk score. Such tools are being tested as decision aids to stratify individuals into potential screening programs according to their future risk of melanoma.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aitken JF, Elwood JM, Lowe JB, Firman DW, Balanda KP, Ring IT (2002) A randomised trial of population screening for melanoma. J Med Screen 9:33–37. https://doi.org/10.1136/jms.9.1.33
Aitken JF, Youlden DR, Baade PD, Soyer HP, Green AC, Smithers BM (2018) Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995–2014. Int J Cancer 142:1528–1535. https://doi.org/10.1002/ijc.31141
American Cancer Society(ACS) (2016) Skin cancer prevention and early detection. https://www.cancer.org/cancer/skin-cancer/prevention-and-early-detection/uv-protection.html. Accessed 18 Nov 2016
Anderson R, Rosenberg H (1998) Age standardization of death rates: implementation of the year 2000 standard. National Vital Stat Rep 47(3):1–16
Armstrong BK, Kricker A (1993) How much melanoma is caused by sun exposure? Melanoma Res 3:395–401
Australian Cancer Network Melanoma Guidelines Revision Working Party (2008). Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group, Wellington, New Zealand
Australian Institute of Health and Welfare (2014) Cancer in Australia: an overview 2014, vol 90. Australian Institute of Health and Welfare, Canberra
Bajaj A, Driver JA, Schernhammer ES (2010) Parkinson’s disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control 21:697–707. https://doi.org/10.1007/s10552-009-9497-6
Bataille V, Snieder H, MacGregor AJ, Sasieni P, Spector TD (2000) Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. J Natl Cancer Inst 92:457–463
Bauer J, Garbe C (2003) Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res 16:297–306
Beadling C et al (2008) KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 14:6821–6828. https://doi.org/10.1158/1078-0432.CCR-08-0575
Bello DM, Ariyan CE, Carvajal RD (2013) Melanoma mutagenesis and aberrant cell signaling cancer control. Cancer Control 20:261–281
Beral V, Robinson N (1981) The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work. Br J Cancer 44:886–891
Berwick M (2015) Dietary advice for melanoma: not ready for prime time. J Clin Oncol 33:2487–2488. https://doi.org/10.1200/JCO.2015.61.8116
Bilmon IA et al (2014) Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study. Bone Marrow Transplant 49:691–698. https://doi.org/10.1038/bmt.2014.13
Boniol M, Autier P, Boyle P, Gandini S (2012) Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ 345:e4757. https://doi.org/10.1136/bmj.e4757bmj.e4757 [pii]
Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, Katalinic A (2012) Systematic skin cancer screening in northern Germany. J Am Acad Dermatol 66:201–211. https://doi.org/10.1016/j.jaad.2010.11.016
Brewer JD et al (2014) Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester epidemiology project population-based study in Minnesota. J Am Acad Dermatol 72(2):302–309. https://doi.org/10.1016/j.jaad.2014.10.028
Cancer Council Australia. (2017) Screening for melanoma. http://www.cancer.org.au/about-cancer/types-of-cancer/skin-cancer/melanoma.html. Accessed 28 Feb 2017
Cancer Research UK (2017) Melanoma – screening. http://www.cancerresearchuk.org/about-cancer/melanoma/getting-diagnosed/screening. Accessed 28 Feb 2017
Cardis E et al (2007) The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiation-related cancer risks. Radiat Res 167:396–416. https://doi.org/10.1667/RR0553.1
Carli P, Massi D, Santucci M, Biggeri A, Giannotti B (1999) Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. J Am Acad Dermatol 40:549–557
Carter JL, Coletti RJ, Harris RP (2015a) Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ 350:g7773. https://doi.org/10.1136/bmj.g7773
Carter SM, Rogers W, Heath I, Degeling C, Doust J, Barratt A (2015b) The challenge of overdiagnosis begins with its definition. BMJ 350:h869. https://doi.org/10.1136/bmj.h869
Chang JW (2013) Acral melanoma: a unique disease in Asia. JAMA Dermatol. 149(11):1273–3. https://doi.org/10.1001/jamadermatol.2013.5941
Chaplin G (2004) Geographic distribution of environmental factors influencing human skin coloration. Am J Phys Anthropol 125:292–302. https://doi.org/10.1002/ajpa.10263
Cho E, Rosner BA, Colditz GA (2005) Risk factors for melanoma by body site. Cancer Epidemiol Biomark Prev 14:1241–1244
Cho HG et al (2018) Melanoma risk prediction using a multilocus genetic risk score in the Women’s health initiative. Cohort J Am Acad Dermatol 79:36–41 e10. https://doi.org/10.1016/j.jaad.2018.02.052
Cress RD, Holly EA (1997) Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988-93. Cancer Causes Control 8:246–252
Criscione VD, Weinstock MA (2010) Melanoma thickness trends in the United States, 1988-2006. J Invest Dermatol 130:793–797. https://doi.org/10.1038/jid.2009.328
Curtin JA et al (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135–2147
Cust AE et al (2011) Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer 128:2425–2435. https://doi.org/10.1002/ijc.25576
Cust AE, Bui M, Goumas C, Jenkins MA (2014) Contribution of MC1R genotype and novel common genomic variants to melanoma risk prediction. Cancer Epidemiol Biomark Prev 23:566–567 (ASPO 38th annual meeting)
Cust AE et al (2018) Assessing the incremental contribution of common genomic variants to melanoma risk prediction in two population-based studies. J Invest Dermatol. https://doi.org/10.1016/j.jid.2018.05.023
Dalvin LA, Damento GM, Yawn BP, Abbott BA, Hodge DO, Pulido JS (2017) Parkinson disease and melanoma: confirming and reexamining an association. Mayo Clin Proc 92:1070–1079. https://doi.org/10.1016/j.mayocp.2017.03.014
de Giorgi V et al (2013) Excess body weight and increased Breslow thickness in melanoma patients: a retrospective study. Eur J Cancer Prev 22:480–485. https://doi.org/10.1097/CEJ.0b013e32835f3b5d
de Waure C et al (2015) Systematic review of studies investigating the association between dietary habits and cutaneous malignant melanoma. Public Health 129:1099–1113. https://doi.org/10.1016/j.puhe.2015.06.015
DeLancey JO, Hannan LM, Gapstur SM, Thun MJ (2011) Cigarette smoking and the risk of incident and fatal melanoma in a large prospective cohort study. Cancer Causes Control 22:937–942. https://doi.org/10.1007/s10552-011-9766-z
Dennis LK, Lowe JB, Lynch CF, Alavanja MC (2008) Cutaneous melanoma and obesity in the agricultural health study. Ann Epidemiol 18:214–221. https://doi.org/10.1016/j.annepidem.2007.09.003
dos Santos SI, De Stavola B, Pizzi C, Evans AD, Evans SA (2013) Cancer incidence in professional flight crew and air traffic control officers: disentangling the effect of occupational versus lifestyle exposures. Int J Cancer 132:374–384. https://doi.org/10.1002/ijc.27612
Dusingize JC et al (2018) Smoking and cutaneous melanoma: findings from the QSkin sun and health cohort study. Cancer Epidemiol Biomark Prev 27(8):874–881. https://doi.org/10.1158/1055-9965.EPI-17-1056
El Ghissassi F et al (2009) A review of human carcinogens – part D: radiation. Lancet Oncol 10:751–752
Elmore JG et al (2017) Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ 357:j2813. https://doi.org/10.1136/bmj.j2813
Elwood JM, Jopson J (1997) Melanoma and sun exposure: an overview of published studies. Int J Cancer 73:198–203
English DR, Armstrong BK, Kricker A (1998) Reproducibility of reported measurements of sun exposure in a case-control study. Cancer Epidemiol Biomark Prev 7:857–863
Erdmann F, Lortet-Tieulent J, Schuz J, Zeeb H, Greinert R, Breitbart EW, Bray F (2012) International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer 132(2):385–400. https://doi.org/10.1002/ijc.27616
Erdmann F, Lortet-Tieulent J, Schuz J, Zeeb H, Greinert R, Breitbart EW, Bray F (2013) International trends in the incidence of malignant melanoma 1953–2008 – are recent generations at higher or lower risk? Int J Cancer 132:385–400. https://doi.org/10.1002/ijc.27616
Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, Thrun S (2017) Dermatologist-level classification of skin cancer with deep neural networks. Nature 542:115–118. https://doi.org/10.1038/nature21056
Famenini S, Martires KJ, Zhou H, Xavier MF, Wu JJ (2014) Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma. J Am Acad Dermatol 72(1):78–84. https://doi.org/10.1016/j.jaad.2014.09.030
Ferlay J et al (2013a) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase no. 11 [internet]. International Agency for Research on Cancer, Lyon, France
Ferlay J et al (2013b) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403. https://doi.org/10.1016/j.ejca.2012.12.027S0959-8049(13)00007-5 [pii]
Ferlay J, Skin HR, Bray, F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127:2893–2917 https://doi.org/10.1002/ijc.25516
Fink CA, Bates MN (2005) Melanoma and ionizing radiation: is there a causal relationship? Radiat Res 164:701–710
Fortes C et al (2010) Identifying individuals at high risk of melanoma: a simple tool. Eur J Cancer Prev 19:393–400. https://doi.org/10.1097/CEJ.0b013e32833b492f
Freedman DM, Sigurdson A, Doody MM, Rao RS, Linet MS (2003) Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes Control 14:847–857
Freedman AN, Seminara D, Gail MH, Hartge P, Colditz GA, Ballard-Barbash R, Pfeiffer RM (2005) Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst 97:715–723. https://doi.org/10.1093/jnci/dji128
Gail MH, Pfeiffer RM (2005) On criteria for evaluating models of absolute risk. Biostatistics 6:227–239. https://doi.org/10.1093/biostatistics/kxi005 6/2/227 [pii]
Gallus S, Naldi L, Martin L, Martinelli M, La Vecchia C (2006) Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy. Melanoma Res 16:83–87
Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, Melchi CF (2005a) Meta-analysis of risk factors for cutaneous melanoma: I. common and atypical naevi. Eur J Cancer 41:28–44
Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, Melchi CF (2005b) Meta-analysis of risk factors for cutaneous melanoma: II sun exposure. Eur J Cancer 41:45–60
Gandini S et al (2005c) Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 41:2040–2059. https://doi.org/10.1016/j.ejca.2005.03.034, S0959-8049(05)00545-9 [pii]
Gandini S, Raimondi S, Gnagnarella P, Dore JF, Maisonneuve P, Testori A (2009) Vitamin D and skin cancer: a meta-analysis. Eur J Cancer 45:634–641. https://doi.org/10.1016/j.ejca.2008.10.003, S0959-8049(08)00802-2 [pii]
Gandini S, Iodice S, Koomen E, Di Pietro A, Sera F, Caini S (2011) Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. Eur J Cancer 47:2607–2617. https://doi.org/10.1016/j.ejca.2011.04.023
Gandini S et al (2018) Alcohol, alcoholic beverages, and melanoma risk: a systematic literature review and dose-response meta-analysis. Eur J Nutr 57(7):2323–2332. https://doi.org/10.1007/s00394-018-1613-5
Garcia-Casado Z et al (2015) BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma. Br J Dermatol 172:1128–1131. https://doi.org/10.1111/bjd.13521
Ghiasvand R, Weiderpass E, Green AC, Lund E, Veierod MB (2016) Sunscreen use and subsequent melanoma risk: a population-based cohort study. J Clin Oncol 34(33):3976–3983. https://doi.org/10.1200/JCO.2016.67.5934
Grajewski B, Waters MA, Yong LC, Tseng CY, Zivkovich Z, Cassinelli RT 2nd (2011) Airline pilot cosmic radiation and circadian disruption exposure assessment from logbooks and company records. Ann Occup Hyg 55:465–475. https://doi.org/10.1093/annhyg/mer024
Gray-Schopfer V, Wellbrock C, Marais R (2007) Melanoma biology and new targeted therapy. Nature 445:851–857. https://doi.org/10.1038/nature05661
Green AC, Olsen CM (2015) Increased risk of melanoma in organ transplant recipients: systematic review and meta-analysis of cohort studies. Acta Derm Venereol 95(8):923–927. https://doi.org/10.2340/00015555-2148
Green AC, Williams GM (2007) Point: sunscreen use is a safe and effective approach to skin cancer prevention. Cancer Epidemiol Biomark Prev 16:1921–1922. https://doi.org/10.1158/1055-9965.EPI-07-0477
Green A, Battistutta D, Hart V, Leslie D, Weedon D (1996) Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour study group. Am J Epidemiol 144:1034–1040
Green A et al (1999) A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 10:21–25
Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370:59–67. https://doi.org/10.1016/S0140-6736(07)61050-2 S0140-6736(07)61050-2 [pii]
Guerin S et al (2003) Radiation dose as a risk factor for malignant melanoma following childhood cancer. Eur J Cancer 39:2379–2386
Gulati R, Gore JL, Etzioni R (2013) Comparative effectiveness of alternative prostate-specific antigen–based prostate cancer screening strategies: model estimates of potential benefits and harms. Ann Intern Med 158:145–153. https://doi.org/10.7326/0003-4819-158-3-201302050-00003
Guy GP Jr et al (2015) Vital signs: melanoma incidence and mortality trends and projections – United States, 1982-2030. MMWR Morb Mortal Wkly Rep 64:591–596
Hacker E, Hayward NK, Dumenil T, James MR, Whiteman DC (2010) The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population. J Invest Dermatol 130:241–248. https://doi.org/10.1038/jid.2009.182
Hacker E et al (2013) NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations. J Invest Dermatol 133:1027–1033. https://doi.org/10.1038/jid.2012.385
Haenssle HA et al (2018) Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists. Ann Oncol 29(8):1836–1842. https://doi.org/10.1093/annonc/mdy166
Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N (2001) Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 12:552–557
Handolias D et al (2010) Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure. Pigment Cell Melanoma Res 23:210–215. https://doi.org/10.1111/j.1755-148X.2010.00671.x
Haugh AM et al (2018) Distinct patterns of acral melanoma based on site and relative sun exposure. J Invest Dermatol 138:384–393. https://doi.org/10.1016/j.jid.2017.08.022
Hayward NK et al (2017) Whole-genome landscapes of major melanoma subtypes. Nature 545:175–180. https://doi.org/10.1038/nature22071
Hery C et al (2010) A melanoma epidemic in Iceland: possible influence of sunbed use. Am J Epidemiol 172:762–767. https://doi.org/10.1093/aje/kwq238
Holman CD, Armstrong BK (1984) Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 73:75–82
Hu S, Parmet Y, Allen G, Parker DF, Ma F, Rouhani P, Kirsner RS (2009) Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida. Arch Dermatol 145:1369–1374. https://doi.org/10.1001/archdermatol.2009.302 145/12/1369 [pii]
Huang P, Yang XD, Chen SD, Xiao Q (2015) The association between Parkinson's disease and melanoma: a systematic review and meta-analysis. Transl Neurodegener 4:21. https://doi.org/10.1186/s40035-015-0044-y
Idorn LW, Wulf HC (2014) Socioeconomic status and cutaneous malignant melanoma in northern Europe. Br J Dermatol 170:787–793. https://doi.org/10.1111/bjd.12800
International Agency for Research on Cancer (IARC) (2007) The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 120:1116–1122. https://doi.org/10.1002/ijc.22453
International Agency for Research on Cancer (IARC) (2012) Solar and UV radiation, IARC monographs on the evaluation of carcinogenic risks to humans. Radiation, vol 100D. IARC, Lyon, pp 35–101
International Agency for Research on Cancer (IARC) (2015) Polychlorinated biphenyls and polybrominated biphenyls. Volume 107. A review of human carcinogens, IARC monographs on the evaluation of carcinogenic risks to humans, no. 107. International Agency for Research on Cancer, Lyon
Inzelberg R, Flash S, Friedman E, Azizi E (2016) Cutaneous malignant melanoma and Parkinson disease: common pathways? Ann Neurol 80:811–820. https://doi.org/10.1002/ana.24802
Jewell R et al (2012) Clinicopathologic features of V600E and V600K melanoma – letter. Clin Cancer Res 18:6792., Author’s reply p 6793. https://doi.org/10.1158/1078-0432.CCR-12-2974
Jiang AJ, Rambhatla PV, Eide MJ (2015) Socioeconomic and lifestyle factors and melanoma: a systematic review. Br J Dermatol 172:885–915. https://doi.org/10.1111/bjd.13500
Joosse A et al (2011) Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol 131:719–726. https://doi.org/10.1038/jid.2010.354
Kabat GC, Kim MY, Hollenbeck AR, Rohan TE (2014) Attained height, sex, and risk of cancer at different anatomic sites in the NIH-AARP diet and health study. Cancer Causes Control 25:1697–1706. https://doi.org/10.1007/s10552-014-0476-1
Katalinic A et al (2012) Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening. Cancer 118:5395–5402. https://doi.org/10.1002/cncr.27566
Katalinic A, Eisemann N, Waldmann A (2015) Skin cancer screening in Germany. Documenting melanoma incidence and mortality from 2008 to 2013. Deutsches Arzteblatt Int 112:629–634. https://doi.org/10.3238/arztebl.2015.0629
Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE, Tate BJ (1994) Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 30:40–48
Kinsler VA et al (2017) Melanoma in congenital melanocytic naevi. Br J Dermatol 176:1131–1143. https://doi.org/10.1111/bjd.15301
Krauthammer M et al (2012) Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 44:1006–1014. https://doi.org/10.1038/ng.2359
Krengel S, Hauschild A, Schafer T (2006) Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol 155:1–8. https://doi.org/10.1111/j.1365-2133.2006.07218.x BJD7218 [pii]
Kubica AW, Brewer JD (2012) Melanoma in immunosuppressed patients. Mayo Clin Proc 87:991–1003. https://doi.org/10.1016/j.mayocp.2012.04.018
Kvaskoff M et al (2013) Site-specific determinants of cutaneous melanoma: a case-case comparison of patients with tumors arising on the head or trunk. Cancer Epidemiol Biomark Prev 22:2222–2231. https://doi.org/10.1158/1055-9965.EPI-13-0475
Kvaskoff M, Bijon A, Mesrine S, Vilier A, Clavel-Chapelon F, Boutron-Ruault MC (2014) Anthropometric features and cutaneous melanoma risk: a prospective cohort study in French women. Cancer Epidemiol 38:357–363. https://doi.org/10.1016/j.canep.2014.05.008
Lahmann PH, Hughes MCB, Williams GM, Green AC (2015) A prospective study of measured body size and height and risk of keratinocyte cancers and melanoma. Cancer Epidemiol 40:119–125
Langard S, Rosenberg J, Andersen A, Heldaas SS (2000) Incidence of cancer among workers exposed to vinyl chloride in polyvinyl chloride manufacture. Occup Environ Med 57:65–68
Lebwohl MG (2015) American Academy of Dermatology (AAD) statement on skin cancer screening (Statement from the President, AAD). American Academy of Dermatology. https://www.aad.org/media/news-releases/aad-statement-on-skin-cancer-screening. Accessed 28 Feb 2017
Lee JH, Choi JW, Kim YS (2011) Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. Br J Dermatol 164:776–784. https://doi.org/10.1111/j.1365-2133.2010.10185.x
Li Z, Gu M, Cen Y (2014) Age at first birth and melanoma risk: a meta-analysis. Int J Clin Exp Med 7:5201–5209
Li Z, Wang Z, Yu Y, Zhang H, Chen L (2015) Smoking is inversely related to cutaneous malignant melanoma: results of a meta-analysis. Br J Dermatol 173(6):1540–1543. https://doi.org/10.1111/bjd.13998
Lindelof B, Krynitz B, Granath F, Ekbom A (2008) Burn injuries and skin cancer: a population-based cohort study. Acta Derm Venereol 88:20–22. https://doi.org/10.2340/00015555-0339
Linet MS et al (1995) Occupational risks for cutaneous melanoma among men in Sweden. J Occup Environ Med 37:1127–1135, PA Hospital Journal holding: 1137(1995)-1142(2000); 1143(2001)- Departmental holdings holding: 1137(1995)-1142(2000);1143(2001)-
Liu W et al (2007) Distinct clinical and pathological features are associated with the BRAF(T1799A (V600E)) mutation in primary melanoma. J Invest Dermatol 127:900–905. https://doi.org/10.1038/sj.jid.5700632
Liu R, Gao X, Lu Y, Chen H (2011) Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology 76:2002–2009. https://doi.org/10.1212/WNL.0b013e31821e554e
Loeb S, Ventimiglia E, Salonia A, Folkvaljon Y, Stattin P (2017) Meta-analysis of the association between phosphodiesterase inhibitors (PDE5Is) and risk of melanoma. J Natl Cancer Inst 109. https://doi.org/10.1093/jnci/djx086
Luke B et al (2015) Cancer in women after assisted reproductive technology. Fertil Steril 104:1218–1226. https://doi.org/10.1016/j.fertnstert.2015.07.1135
Maldonado JL et al (2003) Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95:1878–1890
Marconcini R et al (2018) Current status and perspectives in immunotherapy for metastatic melanoma. Oncotarget 9:12452–12470. https://doi.org/10.18632/oncotarget.23746
Marghoob AA et al (1994) Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study. Arch Dermatol 130:993–998
Masri GD, Clark WH Jr, Dt G, Halpern A, Thompson CJ, Elder DE (1990) Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 22:1042–1048
McArthur GA, Ribas A (2013) Targeting oncogenic drivers and the immune system in melanoma. J Clin Oncol 31:499–506. https://doi.org/10.1200/JCO.2012.45.5568
McKenna MR, Stobaugh DJ, Deepak P (2014) Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-alpha inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration adverse event reporting system. J Gastrointestin Liver Dis 23:267–271. https://doi.org/10.15403/jgld.2014.1121.233.mrmk
McNally RJQ, Basta NO, Errington S, James PW, Norman PD, Craft AW (2014) Socioeconomic patterning in the incidence and survival of children and young people diagnosed with malignant melanoma in northern England. J Invest Dermatol 134:2703–2708. https://doi.org/10.1038/jid.2014.246
Mellemkjaer L, Holmich LR, Gridley G, Rabkin C, Olsen JH (2006) Risks for skin and other cancers up to 25 years after burn injuries. Epidemiology 17:668–673. https://doi.org/10.1097/01.ede.0000239651.06579.a4
Menzies AM et al (2012) Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma. Clin Cancer Res 18:3242–3249. https://doi.org/10.1158/1078-0432.CCR-12-0052
Meyle KD, Gamborg M, Sorensen TIA, Baker JL (2017) Childhood body size and the risk of malignant melanoma in adulthood. Am J Epidemiol 185:673–680. https://doi.org/10.1093/aje/kww128
Miura K, Green AC (2015) Dietary antioxidants and melanoma: evidence from cohort and intervention studies. Nutr Cancer:1–10. https://doi.org/10.1080/01635581.2015.1053499
Moloney FJ et al (2014) Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. JAMA Dermatol 150:819–827. https://doi.org/10.1001/jamadermatol.2014.514
Morton LM et al (2010) Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol 28:4935–4944. https://doi.org/10.1200/JCO.2010.29.1112
Muirhead CR, O’Hagan JA, Haylock RG, Phillipson MA, Willcock T, Berridge GL, Zhang W (2009) Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for radiation workers. Br J Cancer 100:206–212. https://doi.org/10.1038/sj.bjc.6604825
Nelemans PJ, Groenendal H, Kiemeney LA, Rampen FH, Ruiter DJ, Verbeek AL (1993) Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. Environ Health Perspect 101:252–255
New Zealand Ministry of Health (2018) Cancer: Historical Summary 1948-2015. Ministry of Health, New Zealand
Noel SE, Stoneham AC, Olsen CM, Rhodes LE, Green AC (2013) Consumption of omega-3 fatty acids and the risk of skin cancers: a systematic review and meta-analysis. Int J Cancer. https://doi.org/10.1002/ijc.28630
Olsen CM, Green AC (2017) Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: an updated meta-analysis. Ann Rheum Dis 77(8):e49. https://doi.org/10.1136/annrheumdis-2017-212205
Olsen CM et al (2008) Anthropometric factors and risk of melanoma in women: a pooled analysis. Int J Cancer 122:1100–1108. https://doi.org/10.1002/ijc.23214
Olsen CM et al (2009) Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis. Int J Cancer 124:937–944. https://doi.org/10.1002/ijc.24011
Olsen CM, Carroll HJ, Whiteman DC (2010a) Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma. Cancer Prev Res (Phila) 3:233–245. https://doi.org/10.1158/1940-6207.CAPR-09-01081940-6207.CAPR-09-0108 pii
Olsen CM, Carroll HJ, Whiteman DC (2010b) Estimating the attributable fraction for melanoma: a meta-analysis of pigmentary characteristics and freckling. Int J Cancer 127:2430–2445. https://doi.org/10.1002/ijc.25243
Olsen CM et al (2011) Biologic markers of sun exposure and melanoma risk in women: pooled case-control analysis. Int J Cancer 129:713–723. https://doi.org/10.1002/ijc.25691
Olsen CM, Knight LL, Green AC (2014a) Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies. PLoS One 9:e95096. https://doi.org/10.1371/journal.pone.0095096
Olsen CM, Neale RE, Green AC, Webb PM, The QSkin Study, The Epigene Study, Whiteman DC (2014b) Independent validation of six melanoma risk prediction models. J Invest Dermatol 135(5):1377–1384. https://doi.org/10.1038/jid.2014.533
Olsen CM, Lane SW, Green AC (2015a) Increased risk of melanoma in patients with chronic lymphocytic leukaemia: systematic review and meta-analysis of cohort studies. Melanoma Res 26(2):188–194. https://doi.org/10.1097/CMR.0000000000000219
Olsen CM, Neale RE, Green AC, Webb PM, The QSkin Study, The Epigene Study, Whiteman DC (2015b) Independent validation of six melanoma risk prediction models. J Invest Dermatol 135:1377–1384. https://doi.org/10.1038/jid.2014.533
Olsen CM, Wilson LF, Green AC, Bain CJ, Fritschi L, Neale RE, Whiteman DC (2015c) Cancers in Australia attributable to exposure to solar ultraviolet radiation and prevented by regular sunscreen use. Aust N Z J Public Health 39:471–476. https://doi.org/10.1111/1753-6405.12470
Olsen CM, Hyrich KL, Knight LL, Green AC (2016) Melanoma risk in patients with rheumatoid arthritis treated with tumour necrosis factor alpha inhibitors: a systematic review and meta-analysis. Melanoma Res 26:517–523. https://doi.org/10.1097/CMR.0000000000000284
Olsen CM et al (2018) Risk stratification for melanoma: models derived and validated in a purpose-designed prospective cohort. J Natl Cancer Inst 110(10):1075–1083. https://doi.org/10.1093/jnci/djy023
Pandeya N et al (2018) Factors related to nevus-associated cutaneous melanoma: a case-case study. J Invest Dermatol 138(8):1816–1824. https://doi.org/10.1016/j.jid.2017.12.036
Pfeiffer RM et al (2013) Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Med 10:e1001492. https://doi.org/10.1371/journal.pmed.1001492PMEDICINE-D-13-00139 pii
Pirani M, Marcheselli R, Marcheselli L, Bari A, Federico M, Sacchi S (2011) Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis. Ann Oncol 22:1845–1858. https://doi.org/10.1093/annonc/mdq697
Pukkala E et al (2014) Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries. Occup Environ Med 71:398–404. https://doi.org/10.1136/oemed-2013-101803
Qi L et al (2014) Type 2 diabetes mellitus and risk of malignant melanoma: a systematic review and meta-analysis of cohort studies. Iran J Public Health 43:857–866
Rayner JE, Laino AM, Nufer KL, Adams L, Raphael AP, Menzies SW, Soyer HP (2018) Clinical perspective of 3D Total body photography for early detection and screening of melanoma. Front Med (Lausanne) 5:152. https://doi.org/10.3389/fmed.2018.00152
Reigstad MM et al (2015) Cancer risk among parous women following assisted reproductive technology. Hum Reprod 30:1952–1963. https://doi.org/10.1093/humrep/dev124
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578. https://doi.org/10.1016/S0140-6736(08)60269-X, S0140-6736(08)60269-X [pii]
Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LA, Veierod MB (2018) High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry. Clin Epidemiol 10:537–548. https://doi.org/10.2147/CLEP.S151246
Rolon PA, Kramarova E, Rolon HI, Khlat M, Parkin DM (1997) Plantar melanoma: a case-control study in Paraguay. Cancer Causes Control 8:850–856
Rota M et al (2014) Alcohol drinking and cutaneous melanoma risk: a systematic review and dose-risk meta-analysis. Br J Dermatol 170:1021–1028. https://doi.org/10.1111/bjd.12856
Sacchetto L et al (2018) Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer 92:108–118. https://doi.org/10.1016/j.ejca.2017.12.024
Sanlorenzo M et al (2015) The risk of melanoma in airline pilots and cabin crew: a meta-analysis. JAMA Dermatol 151:51–58. https://doi.org/10.1001/jamadermatol.2014.1077
Segi M (1960) Cancer mortality for selected sites in 24 countries (1950–57). Sendai, Japan
Sergentanis TN, Antoniadis AG, Gogas HJ, Antonopoulos CN, Adami HO, Ekbom A, Petridou ET (2013) Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. Eur J Cancer 49:642–657. https://doi.org/10.1016/j.ejca.2012.08.028
Shain AH et al (2015) The genetic evolution of melanoma from precursor lesions. N Engl J Med 373:1926–1936. https://doi.org/10.1056/NEJMoa1502583
Shantha E, Lewis C, Nghiem P (2015) Why do airline pilots and flight crews have an increased incidence of melanoma? JAMA Oncol 1:829–830. https://doi.org/10.1001/jamaoncol.2015.0933
Shors AR, Solomon C, McTiernan A, White E (2001) Melanoma risk in relation to height, weight, and exercise (United States). Cancer Causes Control 12:599–606
Silverberg MJ et al (2011) HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomark Prev 20:2551–2559. https://doi.org/10.1158/1055-9965.EPI-11-0777, pii
Singh S et al (2014) Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 12:210–218. https://doi.org/10.1016/j.cgh.2013.04.033
Skender-Kalnenas TM, English DR, Heenan PJ (1995) Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 33:1000–1007
Song F, Qureshi AA, Gao X, Li T, Han J (2012) Smoking and risk of skin cancer: a prospective analysis and a meta-analysis. Int J Epidemiol 41:1694–1705. https://doi.org/10.1093/ije/dys146dys146 [pii]
Stenehjem JS et al (2018) Anthropometric factors and Breslow thickness: prospective data on 2570 cutaneous melanoma cases in the population-based Janus cohort. Br J Dermatol 179(3):632–641. https://doi.org/10.1111/bjd.16825
Stern RS (2001) The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 44:755–761. https://doi.org/10.1067/mjd.2001.114576, S0190-9622(01)84627-2 [pii]
Sturm RA (2009) Molecular genetics of human pigmentation diversity. Hum Mol Genet 18:R9–R17. https://doi.org/10.1093/hmg/ddp003, ddp003 [pii]
Suarez B et al (2007) Occupation and skin cancer: the results of the HELIOS-I multicenter case-control study. BMC Public Health 7:180. https://doi.org/10.1186/1471-2458-7-180
Sugiyama H et al (2014) Skin cancer incidence among atomic bomb survivors from 1958 to 1996. Radiat Res 181:531–539. https://doi.org/10.1667/rr13494.1
Tang JY et al (2011) Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial. J Clin Oncol 29:3078–3084. https://doi.org/10.1200/JCO.2011.34.5967
Tong LX, Young LC (2014) Nutrition: the future of melanoma prevention? J Am Acad Dermatol 71:151–160. https://doi.org/10.1016/j.jaad.2014.01.910
Tryggvadottir L, Gislum M, Hakulinen T, Klint A, Engholm G, Storm HH, Bray F (2010) Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 49:665–672. https://doi.org/10.3109/02841861003702528
Tseng HW, Shiue YL, Tsai KW, Huang WC, Tang PL, Lam HC (2016) Risk of skin cancer in patients with diabetes mellitus: a nationwide retrospective cohort study in Taiwan. Medicine (Baltimore) 95:e4070. https://doi.org/10.1097/MD.0000000000004070
Tucker MA (2009) Melanoma epidemiology. Hematol Oncol Clin North Am 23:383–395, vii S0889-8588(09)00046-X [pii]. https://doi.org/10.1016/j.hoc.2009.03.010
United States Preventive Services Task Force et al (2016) Screening for skin cancer: US preventive services task force recommendation statement. JAMA 316:429–435. https://doi.org/10.1001/jama.2016.8465
Usher-Smith JA, Emery J, Kassianos AP, Walter FM (2014) Risk prediction models for melanoma: a systematic review. Cancer Epidemiol Biomark Prev 23:1450–1463. https://doi.org/10.1158/1055-9965.EPI-14-0295
Vagero D, Swerdlow AJ, Beral V (1990) Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br J Ind Med 47:317–324
Vajdic CM et al (2009) Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomark Prev 18:2297–2303. https://doi.org/10.1158/1055-9965.EPI-09-0278, 1055-9965.EPI-09-0278 [pii]
Veierod MB, Thelle DS, Laake P (1997) Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer 71:600–604
Viana AC, Gontijo B, Bittencourt FV (2013) Giant congenital melanocytic nevus. An Bras Dermatol 88:863–878. https://doi.org/10.1590/abd1806-4841.20132233
Viros A, Fridlyand J, Bauer J, Lasithiotakis K, Garbe C, Pinkel D, Bastian BC (2008) Improving melanoma classification by integrating genetic and morphologic features. PLoS Med 5:e120. https://doi.org/10.1371/journal.pmed.0050120
Vuong K, McGeechan K, Armstrong BK, Cust AE (2014) Risk prediction models for incident primary cutaneous melanoma: a systematic review. JAMA Dermatol 150(4):434–444. https://doi.org/10.1001/jamadermatol.2013.8890
Vuong K et al (2016) Development and external validation of a melanoma risk prediction model based on self-assessed risk factors. JAMA Dermatol 152:889–896. https://doi.org/10.1001/jamadermatol.2016.0939
Wallingford SC, Olsen CM, Plasmeijer E, Green AC (2011) Skin cancer arising in scars: a systematic review. Dermatol Surg 37:1239–1244. https://doi.org/10.1111/j.1524-4725.2011.02060.x
Wang Y, Zhao Y, Ma S (2016) Racial differences in six major subtypes of melanoma: descriptive epidemiology. BMC Cancer 16:691. https://doi.org/10.1186/s12885-016-2747-6
Watts CG, Cust AE, Menzies SW, Mann GJ, Morton RL (2017) Cost-effectiveness of skin surveillance through a specialized clinic for patients at high risk of melanoma. J Clin Oncol 35:63–71. https://doi.org/10.1200/JCO.2016.68.4308
Weinstock MA (2000) Early detection of melanoma. JAMA 284:886–889
Weinstock MA et al (2017) Skin biopsy utilization and melanoma incidence among medicare beneficiaries. Br J Dermatol 176:949–954. https://doi.org/10.1111/bjd.15077
Welch HG, Black WC (2010) Overdiagnosis in cancer. J Natl Cancer Inst 102:605–613. https://doi.org/10.1093/jnci/djq099
Welch HG, Passow HJ (2014) Quantifying the benefits and harms of screening mammography. JAMA Intern Med 174:448–454. https://doi.org/10.1001/jamainternmed.2013.13635
Whiteman DC, Parsons PG, Green AC (1998) p53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer 77:843–848
Whiteman DC, Whiteman CA, Green AC (2001) Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12:69–82
Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC (2003) Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 95:806–812
Whiteman DC, Stickley M, Watt P, Hughes MC, Davis MB, Green AC (2006) Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 24:3172–3177
Whiteman DC, Green AC, Olsen CM (2016) The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol 136:1161–1171. https://doi.org/10.1016/j.jid.2016.01.035
Wilson JMG, Jungner G (1968) Principles and practice of screening for disease. WHO, Geneva
Wiren S et al (2014) Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 25:151–159. https://doi.org/10.1007/s10552-013-0317-7
Wolfe F, Michaud K (2007) Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 56:2886–2895. https://doi.org/10.1002/art.22864
Wolff T, Tai E, Miller T (2009) Screening for skin cancer: an update of the evidence for the U.S. preventive services task force. Ann Intern Med 150:194–198, 150/3/194 [pii]
Wu S, Han J, Feskanich D, Cho E, Stampfer MJ, Willett WC, Qureshi AA (2015) Citrus consumption and risk of cutaneous malignant melanoma. J Clin Oncol 33:2500–2508. https://doi.org/10.1200/JCO.2014.57.4111
Zahl PH, Jorgensen KJ, Gotzsche PC (2013) Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis. Br J Cancer 109:2014–2019. https://doi.org/10.1038/bjc.2013.427
Zhu G et al (1999) A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 65:483–492
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Olsen, C.M., Whiteman, D.C. (2020). Clinical Epidemiology of Melanoma. In: Balch, C., et al. Cutaneous Melanoma. Springer, Cham. https://doi.org/10.1007/978-3-030-05070-2_47
Download citation
DOI: https://doi.org/10.1007/978-3-030-05070-2_47
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-05068-9
Online ISBN: 978-3-030-05070-2
eBook Packages: MedicineReference Module Medicine